Hypertension affects 1.7 billion adults globally, rising sharply in poorer nations. In India, 220 million live with it. Experts warn lean individuals are also at risk and urge regular checkups.
About The Author
Archana Jyoti is a senior journalist with nearly 17 years of experience across crime, education, disability, environment, governance, public policy, and health systems. She has worked with leading organisations including PTI, The Asian Age, and The Pioneer, where she independently handled a dedicated health page. Her core strength lies in health and pharmaceutical reporting, driven by a strong public-interest approach and a commitment to equity, inclusion, and diversity. She is a recipient of the CMS–WHO Media Fellowship, CMS-BEEP Media Fellowship, and the India Science–UK Alliance Wellcome Trust Media Fellowship among a few others. She also enjoys handcrafting and travelling.
A global study warns that climate change erodes vital social bonds, worsening public health risks like loneliness. India and other developing nations must build social, resilient infrastructure.
The Union Ayush Ministry's and MeitY's BHASHINI division are launching AI translation tools to offer digital healthcare services in 22 languages, breaking linguistic barriers across India.
Ultra-processed foods raise heart disease risk by 19% and alter biology. Experts urge regulation and early healthy habits to combat rising consumption in urban centres.
India's TDB is supporting Helix Cell Therapeutics to develop an affordable, dual-targeting CAR-T therapy for multiple myeloma, aiming to improve treatment outcomes via Indo-Singapore collaboration.
AIIMS Delhi revived its pancreas-kidney transplant program, successfully treating a patient with Type 1 diabetes and kidney failure via a complex surgery and a "green corridor" for organ transport.
Eli Lilly launches Lormalzi in India, a once-monthly Alzheimer's therapy for mild impairment. It targets amyloid plaques to slow cognitive decline as dementia cases are set to double by 2036.
Experts warn India needs a long-term strategy against rising dengue. CSIR-CDRI is developing advanced antivirals and antibodies to tackle all serotypes, aiming for clinical trials within five years.
Affordable Chinese-origin immunotherapy is helping Indian families like Ramesh Kumar's access cancer care, reducing costs by half and preventing financial ruin as local innovation also grows.
AIIMS Delhi launched a low-cost blood testing facility for epilepsy patients. This "precision medicine" tool helps doctors personalise drug dosages to prevent seizures while avoiding toxic side effects.
Newsletter
Signup for Outlook and get curated content to your inbox everyday.